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Background
Public involvement is health research policy in the UK
and internationally. There is a need to establish a robust
evidence base on the impact of public involvement on
research processes and outcomes.
Aim
To review case examples of public involvement in the
design and conduct of clinical trials, to synthesise the
contributions of the public, as well as the identified ten-
sions and facilitating strategies.
Method
Systematic literature search and narrative review.
Findings
Nine papers were identified, covering the following
topics: breast-feeding, antiretroviral and nutrition inter-
ventions [1]; paediatric resuscitation [2]; exercise and
cognitive behavioural therapy [3]; hormone replacement
therapy and breast cancer [4]; stroke [5,6]; chronic sup-
purative otitis media [7]; Paget’s disease [8]; and shared
decision-making in patient consultations [9]. Six papers
reported on public involvement at the trial design stage,
while three reported on public involvement at the
design and conduct stages of clinical trials. It was found
that the public contributed at the consultation, colla-
boration and publicly-led levels of involvement. Four
main public contributions to trial design were identified:
review of consent procedures and patient information
sheets; suggestion of additional trial outcomes; review of
trial data collection procedures; and recommendations
on the timing and location of trial follow-up data
collection. Two main contributions that the public made
to the conduct of trials were identified: scrutiny of the
conduct of the trial through membership of the Trial
Steering Committee; and delivering the trial protocol
after completing relevant training. Four main tensions
were identified with regard to involving the public in
trial design and conduct: tensions between stakeholder
groups when designing trials; public understanding of
trial methodology; the added time, complexity and cost
of public involvement; and the representativeness of the
public involved. Four main facilitating strategies were
identified with regard to involving the public in trial
design and conduct: cultural sensitivity; clear explana-
tion of trial methodology; independent facilitation of
trial design planning meetings; and adequate funding for
public involvement.
Limitations
Papers on public involvement in the design and conduct
of clinical trials may have been overlooked due to the
difficulty of searching for, and identifying, papers in this
area. Only publications published in English were
searched for and the review focused on evidence con-
tained in peer-reviewed journal articles only.
Conclusions
The issues raised in this review should assist researchers
in developing and conducting clinical trials with the
involvement of the public.
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